CAR-BCMA-T-cell/cyclophosphamide/fludarabine

Cytokine release syndrome and idiopathic thrombocytopenic purpura: case report

    This is a preview of subscription content, log in to check access.

    Reference

    1. Qiu L, et al. Idiopathic thrombocytopenic purpura treatment in a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T cell therapy. Regenerative Therapy 14: 271-274, Jun 2020. Available from: URL: http://doi.org/10.1016/j.reth.2020.03.005

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    CAR-BCMA-T-cell/cyclophosphamide/fludarabine. Reactions Weekly 1809, 77 (2020). https://doi.org/10.1007/s40278-020-79861-2

    Download citation